CDKN2D Antikörper (AA 1-166)

Produktnummer ABIN7445234

Produktdetails anti-CDKN2D Antikörper

Target: CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))

Bindungsspezifität: AA 1-166

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDKN2D Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Verwendungszweck: Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2D (CDKN2D)

Spezifität: The antibody is a rabbit polyclonal antibody raised against CDKN2D. It has been selected for its ability to recognize CDKN2D in immunohistochemical staining and western blotting.

Kreuzreaktivität: Human, Ratte

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: Recombinant Cyclin Dependent Kinase Inhibitor 2D (CDKN2D) corresdonding to Met1~Met166

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western blotting: 0.5-2 μg/mL

Immunohistochemistry: 5-20 μg/mL

Immunocytochemistry: 5-20 μg/mL

Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Haltbarkeit: 24 months

Details zu CDKN2D

Target: CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))

Andere Bezeichnung: Cyclin Dependent Kinase Inhibitor 2D (CDKN2D Produkte)

Synonyme: ink4d antikoerper, p19 antikoerper, p19-ink4d antikoerper, CDKN2D antikoerper, ank2 antikoerper, INK4D antikoerper, p19-INK4D antikoerper, INK4d antikoerper, p19INK4d antikoerper, cyclin-dependent kinase inhibitor 2D S homeolog antikoerper, cyclin dependent kinase inhibitor 2D antikoerper, cyclin-dependent kinase inhibitor 2D antikoerper, Cyclin-dependent kinase 4 inhibitor D antikoerper, cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) antikoerper, similar to cyclin-dependent kinase inhibitor 2D antikoerper, cdkn2d.S antikoerper, CDKN2D antikoerper, cdkn2d antikoerper, cdn2d antikoerper, Cdkn2d antikoerper

Hintergrund: INK4D, p19, p19-INK4D, Cyclin-dependent kinase 4 inhibitor D

Pathways: Zellzyklus, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling